Related topics: cancer , cells , breast cancer , cancer cells , immune cells
Journal of Clinical Investigation
hideThe Journal of Clinical Investigation (JCI or J Clin Invest) is a leading biomedical journal, with a 2008 impact factor of 16.559. The journal makes its research articles -- including access to articles back to 1924 -- freely available online.
The website of the journal describes it as "a premier venue for critical advances in biomedical research, authoritative reviews, and commentaries that place research articles in context." The first issue of the journal appeared in 1924, and within a few decades, it had established itself as a reputed journal for primary clinical research.
The JCI's Editorial Board is unique in that its members are located chiefly at a singular academic medical center and are predominantly members of the American Society for Clinical Investigation. The leadership of the Editorial Board changes every five years: As of March 2007, the Editorial Board is located at the University of Pennsylvania under the leadership of Laurence A. Turka, M.D. From March 2002 to March 2007, the Editorial Board was located at Columbia University under the leadership of Andrew Marks, M.D. Ushma S. Neill, formerly with Nature Medicine, is the journal's Executive Editor.
This monthly journal publishes original research and review articles, including periodic review series focusing on important topics in biomedicine.
For more information about Journal of Clinical Investigation, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with journal of clinical investigation
New understanding of how to prevent destruction of a tumor suppressor
Dec 07, 2009 |
not rated yet |
0
Researchers from the Indiana University School of Medicine and colleagues at the University of Texas Southwestern and Case Western University have determined how the protein Mdm2, which is elevated in late-stage ...
Why Some Monkeys Don't Get AIDS
Medicine & Health / HIV & AIDS
Dec 03, 2009 |
not rated yet |
0
(PhysOrg.com) -- Two studies published this month in the Journal of Clinical Investigation provide a significant advance in understanding how some species of monkeys such as sooty mangabeys and African green ...
Death-inducing proteins key to complications of bone marrow transplantation
Dec 01, 2009 |
not rated yet |
0
Treatment for a number of cancers and other medical conditions is transplantation with bone marrow from a genetically nonidentical individual (a process known as allogeneic bone marrow transplantation [allo-BMT]).
Scientists identify possible therapy target for aggressive cancer
Dec 01, 2009 |
5 / 5 (1) |
0
UT Southwestern Medical Center researchers have found that a naturally occurring protein -- transforming growth factor beta1 (TGF-ß1) -- which normally suppresses the growth of cancer cells, causes a rebound effect after ...
Scientists discover cells that control inflammation in chronic disease
Nov 17, 2009 |
5 / 5 (2) |
0
(PhysOrg.com) -- A new type of immune cell that can be out of control in certain chronic inflammatory diseases, worsening the symptoms of conditions like psoriasis and asthma, is described for the first time ...
Watching Lyme disease-causing microbes move in ticks
Nov 16, 2009 |
not rated yet |
0
Lyme disease is caused by the microbe Borrelia burgdorferi, which is transmitted to humans from feeding ticks.
Researchers find inflammation critical in aortic dissection
Nov 16, 2009 |
not rated yet |
0
The aorta, the body's largest artery, stretches from the chest to below the kidneys, expanding and contracting with the pressure of blood driven directly into it by the heart. Although its walls are extraordinarily strong, ...
Wistar researchers show targeting 'normal' cells in tumors slows growth
Nov 16, 2009 |
1 / 5 (1) |
0
Targeting the normal cells that surround cancer cells within and around a tumor is a strategy that could greatly increase the effectiveness of traditional anti-cancer treatments, say researchers at The Wistar Institute.
Study provides first clear idea of how rare bone disease progresses
Nov 12, 2009 |
5 / 5 (1) |
0
An international team of scientists, led by researchers at the University of Pennsylvania School of Medicine, is taking the first step in developing a treatment for a rare genetic disorder called fibrodysplasia ...
NSAIDs prevent early sign of Alzheimer disease in mice
Nov 09, 2009 |
not rated yet |
0
If taking nonsteroidal antiinflammatory drugs (NSAIDs) such as ibuprofen or naproxen is to protect you from developing Alzheimer disease then you will have to start taking them at a very early age according to new research ...
Cellular Source of Most Common Type of Abnormal Heart Beat Found
Nov 02, 2009 |
5 / 5 (1) |
1
(PhysOrg.com) -- While studying how the heart is formed, scientists at the University of Pennsylvania School of Medicine serendipitously found a novel cellular source of atrial fibrillation (AF), the most ...
Immune cells predict outcome of West Nile virus infection
Oct 12, 2009 |
not rated yet |
0
Infection with West Nile virus (WNV) causes no symptoms in most people. However, it can cause fever, meningitis, and/or encephalitis. What determines the outcome of infection with WNV in different people has not been determined. ...
Iron regulates the TLR4 inflammatory signaling pathway
Oct 05, 2009 |
not rated yet |
0
Iron is a micronutrient essential to the survival of both humans and disease-causing microbes. Changes in iron levels therefore affect the severity of infectious diseases. For example, individuals with mutations in their ...
Mutated FGFR4 protein helps a childhood cancer spread
Oct 05, 2009 |
not rated yet |
0
Rhabdomyosarcoma (RMS) is a childhood cancer thought to originate from skeletal muscle. In patients whose disease has spread (metastasized) from the initial tumor site the chance of long-term survival is poor. Hopes for a ...
Immune response to spinal cord injury may worsen damage
Sep 21, 2009 |
not rated yet |
0
After spinal cord injury, certain immune cells collect in the spinal fluid and release high levels of antibodies. What, if anything, those antibodies do there is unknown.
